Komori
Giken (6289) · TargetAchieved

Achievement Conditions of Net Sales of ¥27.5 Billion and Operating Profit of ¥5.8 Billion for the Fiscal Year Ended August 2018

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2018.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q2RaisedFY2018-Q3 – FY20182016: 120162017: 120172018: 32018
Same theme, other companies
Sales and Operating Profit Compound Achievement-Linked Stock Acquisition RightsA theme 17 companies write about · 4 as a headwind · 14 as a tailwind

The whole theme swung hardest in 2026: 1 of 6 companies on the "Worse" side.

2 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 17 companies compared. The sentences above are computed from all 17.
Full recordFilings, disclosures and news, newest first
  1. FY2018AchievedAnnual report

    「Profit also increased, with operating profit of ¥5,977 million, up 16.6% year on year, ordinary profit of ¥6,069 million, up 16.8%, and net income attributable to owners of the parent of ¥4,151 million, up 13.1%, thereby achieving the medium-term management plan's financial targets of sales of ¥27.5 billion and operating profit of ¥5.8 billion.」

    The financial targets of the former medium-term management plan for the fiscal year ending August 2018, namely sales of ¥27.5 billion and operating profit of ¥5.8 billion, were achieved.
  2. FY2018-Q3RaisedAnnual report

    「Based on the “Medium-Term Management Plan (fiscal years ending August 2016 to August 2018),” our Group is pursuing the basic strategies of ① global expansion through packaging the implant construction method, ② further strengthening an organizational structure focused on development, and ③ making Kochi the world's center for jacking technology. In line with the revised forecast announced when the second-quarter results were released, we are working diligently to achieve the target financial plan of sales of ¥29.0 billion and operating profit of ¥5.8 billion.」

    Under the revised forecast, the sales target was raised from ¥27.5 billion to ¥29.0 billion, while the operating profit target was maintained at ¥5.8 billion.
  3. FY2018-Q2RestatedAnnual report

    「Based on the “Medium-Term Management Plan (fiscal years ending August 2016 to August 2018),” our Group is promoting ① global expansion through packaging the implant construction method, ② further strengthening an organizational structure focused on development, and ③ making Kochi the world's center for jacking technology, and is working diligently to achieve its target financial plan of sales of ¥27.5 billion and operating profit of ¥5.8 billion.」

    The Group continues to aim to achieve its financial targets of sales of ¥27.5 billion and operating profit of ¥5.8 billion for the fiscal year ending August 2018.
  4. FY2017RestatedAnnual report

    「《Financial targets》 Sales: ¥27,500 million; operating profit: ¥5,800 million (consolidated, fiscal year ending August 2018)」

    The financial targets of sales of ¥27.5 billion and operating profit of ¥5.8 billion for the fiscal year ending August 2018 continue to be maintained.
  5. FY2016First statedAnnual report

    「① If consolidated sales for the fiscal year ending August 2018 are ¥27,500 million or more: 50% of the total number of these stock acquisition rights allocated to each holder. ② If consolidated operating profit for the fiscal year ending August 2018 is ¥5,800 million or more: 50% of the total number of these stock acquisition rights allocated to each holder.」

    For the fiscal year ending August 2018, sales of ¥27.5 billion or more and operating profit of ¥5.8 billion or more were established as separate exercise conditions for the stock options.
Moved together

"Global Expansion Through Packaging of the Implant Construction Method" moved the same way as this thread, in the same document, in 2 of its 5 moves.

2222★1234
  1. ★This thread
  2. 1Global Expansion Through Packaging of the Implant Construction Method2×
  3. 2Development of Equipment and Construction Methods for Diverse Construction Conditions, Pile Materials and Large-Diameter Piles2×
  4. 3Recognition of the advantages of the implant construction method and its expanding adoption in various regions2×
  5. 4Increase in Capital and Capital Reserve Through Exercise of Stock Acquisition Rights2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Giken's next results are scheduled for 2026-10-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Achievement Conditions of Net Sales of ¥27.5 Billion and Operating Profit of ¥5.8 Billion for the Fiscal Year Ended August 2018 | GIKEN LTD. (6289) | Komori